Draft genome sequence of a KPC-2-producing, meropenem-durlobactam non-susceptible <i>Klebsiella pneumoniae</i> ST11-KL64 clinical isolate
We report the draft genome of a clinically isolated <i>Klebsiella pneumoniae</i> ST11-KL64 strain 143027 that is non-susceptible to the meropenem-durlobactam combination (minimum inhibitory concentration [MIC], 256/4 μg/mL). This genome sequence provides a foundation for investigating reduced susceptibility to emerging carbapenem-β-lactamase inhibitor combinations used to treat infections caused by carbapenem-resistant <i>K. pneumoniae</i>.
Authors
- Zhiyong Zong
- Hongxia Wen
- Yu Feng
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- State Key Laboratory of Biotherapy
Publication Details
- Journal
- Microbiology Resource Announcements
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1128/mra.00046-26
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00